Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29770319 | 1.00 | CSNK2A1 (0.39) | CSNK2A1 | |
| SCHEMBL28351736 | 0.85 | CSNK2A1 (0.39) | CSNK2A1 | |
| SCHEMBL7749525 | 0.72 | DAO (0.31) | — | |
| SCHEMBL29377568 | 0.72 | DAO (0.31) | — | |
| SCHEMBL28281829 | 0.69 | GPR84 (0.43) | — | |
| SCHEMBL1921362 | 0.69 | CSNK2A1 (0.43) | CSNK2A1 | |
| Phosphoric Acid SCHEMBL28462485 | 0.67 | CSNK2A1 (0.73) | CSNK2A1 | |
| SCHEMBL17351236 | 0.66 | CSNK2A1 (0.48) | CSNK2A1 | |
| SCHEMBL14889487 | 0.66 | CSNK2A1 (0.48) | CSNK2A1 | |
| SCHEMBL28664360 | 0.65 | DAO (0.56) | CSNK2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4246147-B1 | METHOD FOR MEASURING STEROL IN LIPOPROTEIN, AND REAGENT FOR MEASURING STEROL IN LIPOPROTEIN | SYSMEX CORP (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-3855182-B1 | METHOD FOR OBTAINING INFORMATION ON COGNITIVE FUNCTION | SYSMEX CORP (JP) | 2026-04-29 | — | — | EP | disclosed |
| EP-3779457-B1 | METHOD AND REAGENT FOR MEASURING UPTAKE PERFORMANCE OF LIPOPROTEIN | SYSMEX CORP (JP) | 2026-04-29 | — | — | EP | disclosed |
| EP-4047017-B1 | MONOCLONAL ANTIBODY, MEASUREMENT REAGENT FOR CYTOKERATIN 18 FRAGMENT, REAGENT KIT, AND MEASUREMENT METHOD | SYSMEX CORP (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-3809135-B1 | METHOD AND REAGENT FOR MEASURING LIPOPROTEIN'S UPTAKE ABILITY | SYSMEX CORP (JP) | 2026-01-14 | — | — | EP | disclosed |
| EP-4623995-A1 | MONOCLONAL ANTIBODY, REAGENT FOR MEASURING CRTAC1B, REAGENT KIT, AND METHOD FOR MEASURING CRTAC1B | SYSMEX CORPORATION (JP) | 2025-10-01 | — | — | EP | disclosed |
| US-20250296994-A1 | MONOCLONAL ANTIBODY, REAGENT FOR MEASURING CRTAC1B, REAGENT KIT, AND METHOD FOR MEASURING CRTAC1B | SYSMEX CORPORATION (JP) | 2025-09-25 | — | — | US | disclosed |
| US-12422429-B2 | Methods for reducing noise in signal-generating digital assays | ABBOTT JAPAN LLC (JP) | 2025-09-23 | — | — | US | disclosed |
| EP-3798000-B1 | LIQUID-SEALED CARTRIDGE AND LIQUID SENDING METHOD | SYSMEX CORP (JP) | 2025-07-23 | — | — | EP | disclosed |
| EP-3699593-B1 | METHOD FOR ACQUIRING INFORMATION ON ANALYTE | SYSMEX CORP (JP) | 2025-06-18 | — | — | EP | disclosed |
| US-20170205428-A1 | METHOD FOR DETECTING CARDIAC FAILURE PATIENT | MATSUMORI AKIRA (JP) | 2017-07-20 | — | — | US | disclosed |
| EP-3141906-A1 | IMMUNE MEASURING APPARATUS AND IMMUNE MEASURING METHOD | SYSMEX CORPORATION (JP) | 2017-03-15 | — | — | EP | disclosed |
| US-20170059562-A1 | IMMUNE MEASURING APPARATUS AND IMMUNE MEASURING METHOD | SYSMEX CORPORATION (JP) | 2017-03-02 | — | — | US | disclosed |
| EP-2950099-A1 | PRETREATMENT METHOD FOR SAMPLE FOR DETECTING HBS ANTIGEN, AND USE THEREFOR | Sysmex Corporation (JP) | 2015-12-02 | — | — | EP | disclosed |
| US-20150330982-A1 | PRETREATMENT METHOD OF SAMPLE FOR DETECTING HBS ANTIGEN AND USE THEREOF | SYSMEX CORPORATION (JP) | 2015-11-19 | — | — | US | disclosed |
| EP-2327987-B1 | Method and kit for detection of HCV core protein | SYSMEX CORP (JP) | 2013-08-21 | — | — | EP | disclosed |
| US-8492166-B2 | Particle suspension and reagent kit for use in immunoassay | SYSMEX CORPORATION (JP) | 2013-07-23 | — | — | US | disclosed |
| US-20110129815-A1 | METHOD FOR PRETREATING SAMPLE FOR DETECTION HCV CORE PROTEIN, REAGENT KIT FOR DETECTION OF HCV CORE PROTEIN, METHOD FOR DETERMINING THE PRESENCE OR ABSENCE OF HEPATITIS C VIRUS IN SAMPLE, AND METHOD FOR IMMUNOASSAY OF HCV | SYSMEX CORPORATION (JP) | 2011-06-02 | — | — | US | disclosed |
| EP-2327987-A2 | Method for pretreating sample for detection of HCV core protein, reagent kit for detection of HCV core protein, method for determining the presence or absence of hepatitis C virus in sample, and method for immunoassay of HCV | SYSMEX CORPORATION (JP) | 2011-06-01 | — | — | EP | disclosed |
| US-20110053176-A1 | PARTICLE SUSPENSION AND REAGENT KIT FOR USE IN IMMUNOASSAY | SYSMEX CORPORATION (JP) | 2011-03-03 | — | — | US | disclosed |